Literature DB >> 16076630

Variation in the vitamin D receptor gene is associated with multiple sclerosis in an Australian population.

Lotti Tajouri1, Micky Ovcaric, Rob Curtain, Matthew P Johnson, Lyn R Griffiths, Peter Csurhes, Michael P Pender, Rod A Lea.   

Abstract

Multiple Sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system (CNS) resulting in accumulating neurological disability. The disorder is more prevalent at higher latitudes. To investigate VDR gene variation using three intragenic restriction fragment length polymorphisms (Apa I, Taq I and Fok I) in an Australian MS case-control population. One hundred and four Australian MS patients were studied with patients classified clinically as Relapsing Remitting MS (RR-MS), Secondary Progressive MS (SP-MS) or Primary Progressive MS (PP-MS). Also, 104 age-, sex-, and ethnicity-matched controls were investigated as a comparative group. Our results show a significant difference of genotype distribution frequency between the case and control groups for the functional exon 9 VDR marker Taq I (p(Gen) = 0.016) and interestingly, a stronger difference for the allelic frequency (p(All) = 0.0072). The Apa I alleles were also found to be associated with MS (p(All) = 0.04) but genotype frequencies were not significantly different from controls (p(Gen) = 0.1). The Taq and Apa variants are in very strong and significant linkage disequilibrium (D' = 0.96, P < 0.0001). The genotypic associations are strongest for the progressive forms of MS (SP-MS and PP-MS). Our results support a role for the VDR gene increasing the risk of developing multiple sclerosis, particularly the progressive clinical subtypes of MS.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16076630     DOI: 10.1080/01677060590949692

Source DB:  PubMed          Journal:  J Neurogenet        ISSN: 0167-7063            Impact factor:   1.250


  28 in total

Review 1.  Multiple sclerosis, vitamin D, and HLA-DRB1*15.

Authors:  Lahiru Handunnetthi; Sreeram V Ramagopalan; George C Ebers
Journal:  Neurology       Date:  2010-06-08       Impact factor: 9.910

Review 2.  Genomic binding sites and biological effects of the vitamin D--VDR complex in multiple sclerosis [corrected].

Authors:  Bernadette Kalman; Erzsebet Toldy
Journal:  Neuromolecular Med       Date:  2014-04-08       Impact factor: 3.843

3.  Polymorphisms in vitamin D metabolism related genes and risk of multiple sclerosis.

Authors:  K Claire Simon; Kassandra L Munger; Alberto Ascherio
Journal:  Mult Scler       Date:  2009-12-09       Impact factor: 6.312

4.  Multiple sclerosis patients have a diminished serologic response to vitamin D supplementation compared to healthy controls.

Authors:  Pavan Bhargava; Sonya U Steele; Emmanuelle Waubant; Nisha R Revirajan; Jacqueline Marcus; Marieme Dembele; Sandra D Cassard; Bruce W Hollis; Ciprian Crainiceanu; Ellen M Mowry
Journal:  Mult Scler       Date:  2015-08-18       Impact factor: 6.312

Review 5.  Association between vitamin D receptor polymorphisms and multiple sclerosis: systematic review and meta-analysis of case-control studies.

Authors:  Kalthoum Tizaoui; Wajih Kaabachi; Agnès Hamzaoui; Kamel Hamzaoui
Journal:  Cell Mol Immunol       Date:  2014-07-07       Impact factor: 11.530

Review 6.  Association between VDR polymorphisms and multiple sclerosis: systematic review and updated meta-analysis of case-control studies.

Authors:  Yan-Jie Zhang; Li Zhang; Shan-Yu Chen; Guo-Jun Yang; Xiao-Lei Huang; Yu Duan; Li-Juan Yang; Dong-Qing Ye; Jing Wang
Journal:  Neurol Sci       Date:  2017-11-06       Impact factor: 3.307

Review 7.  The implication of vitamin D and autoimmunity: a comprehensive review.

Authors:  Chen-Yen Yang; Patrick S C Leung; Iannis E Adamopoulos; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2013-10       Impact factor: 8.667

8.  Serum 25-hydroxyvitamin D level and vitamin D receptor (VDR) polymorphisms in patients infected with Leishmania tropica: a case control study.

Authors:  Hajar Shabandoust; Iraj Sharifi; Omid Raiesi; Muhammad Ibrahim Getso; Ebrahim Dezaki Saedi; Ali Afgar; Giti Shirvani; Ehsan Salarkia; Zahra Babaei
Journal:  J Parasit Dis       Date:  2019-09-26

Review 9.  Clinical implications of a possible role of vitamin D in multiple sclerosis.

Authors:  Charles Pierrot-Deseilligny
Journal:  J Neurol       Date:  2009-04-28       Impact factor: 4.849

10.  Evidence for genetic regulation of vitamin D status in twins with multiple sclerosis.

Authors:  Sarah-Michelle Orton; Andrew P Morris; Blanca M Herrera; Sreeram V Ramagopalan; Matthew R Lincoln; Michael J Chao; Reinhold Vieth; A Dessa Sadovnick; George C Ebers
Journal:  Am J Clin Nutr       Date:  2008-08       Impact factor: 7.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.